{"schema_version":"secwatch.filing_event.v1","accession":"0001552781-22-000630","form_type":"8-K","ticker":"SWKHL","cik":"0001089907","company_name":"SWK Holdings Corp","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.577203+00:00","generated_at":"2026-06-22T00:35:29.406207+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SWK Holdings Q3 GAAP net income $6.6M ($0.51/diluted share), revenue up 42% YoY; names new CEO and CFO","bullets":["GAAP net income $6.6M ($0.51 per diluted share) vs $2.2M ($0.17) in Q3 2021, up 195%.","Total revenue $13.6M, up 42.4% YoY, driven by $5.0M milestone from Cara Therapeutics.","Finance receivables adjusted non-GAAP net income $6.0M, down 22.3% from $7.7M YoY.","Closed three new financings totaling $57.5M committed capital during the quarter.","Leadership transition: Jody Staggs named President and Interim CEO; Yvette Heinrichson named CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001552781-22-000630","json":"https://secwatch.observer/filing/0001552781-22-000630.json","markdown":"https://secwatch.observer/filing/0001552781-22-000630.md","text":"https://secwatch.observer/filing/0001552781-22-000630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1089907/000155278122000630/0001552781-22-000630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1089907/000155278122000630/e22495_swkh-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:35:29.406207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef557dfdd7aafbbbd8fed82a42deefe6169c34cf","claim":"SWK Holdings Corp reported the third quarter ended September 30, 2022 results: revenue $13.6 million, net income $6.6 million, or $0.51 per diluted share, EPS $0.51 per diluted share.","evidence_excerpt":"drive value creation for SWK, translating to solid returns for our shareholders.” Third Quarter 2022 Financial Results For the third quarter 2022, SWK reported total revenue of $13.6 million, a 42.4% increase compared to $9.6 million for the third quarter 2021. The $4.0 million increase in revenue was primarily due to $5.0 million of milestone revenue related to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1089907/000155278122000630/0001552781-22-000630-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$13.6 million"},{"label":"Net income","value":"$6.6 million, or $0.51 per diluted share"},{"label":"EPS","value":"$0.51 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}